Home > PJ (current issue) > Letters | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 270 No 7255 p887
28 June 2003

This page
Reprint
Photocopy

   

PDF* 100K

Letters

  Modernisation
  Technicians
  Omeprazole
  Paroxetine
  Drug tariff
  Penicillin
  Onlooker


Letters to the Editor

  * PDF files on PJ Online require Acrobat Reader 4 or later.

Paroxetine

Alternate day regimen unhelpful

From Mr S. G. Bleakley, MRPharmS

The recent advice from the Medicines and Healthcare products Regulatory Agency concerning paroxetine in children (PJ, 14 June, p813) suggests that paroxetine should not be stopped suddenly but tapered slowly then taken on alternate days. Although I would concur with much of this advice, it is our experience that an alternate day regimen in paroxetine withdrawal is unhelpful.

Paroxetine has been associated with a greater number of discontinuation reports than other selective serotonin reuptake inhibitors.1 This may be due to its short half-life (24 hours) and its ability to inhibit its own metabolism via a concentration-dependent effect. Consequently withdrawal symptoms may appear after one day of abrupt cessation.

With alternate day dosing patients can experience withdrawal symptoms on one day but not the next. A more patient friendly approach is a slow tapering of the dose, using the liquid if required, over at least four weeks but continuing with a daily dose.

References

1. Olver J, Burrows G, Norman T. Discontinuation syndromes with selective serotonin reuptake inhibitors. Are there clinically relevant differences? CNS Drugs 1999;12:171–7.

Stephen Bleakley
Medicines Information Pharmacist
National Psychiatry Medicines Information Centre,
Maudsley Hospital, London

Send your letter to The Editor

Previous Topic (Omeprazole)
Next Topic (Drug tariff)

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal